SNP Therapeutics is a Precision Nutrition company dedicated to identifying people who have inefficiencies or roadblocks in metabolism that are caused by common genetic variants or SNPs (single nucleotide polymorphisms) that lead to health problems and diseases.  The company’s genetic tests are developed from human clinical research to identify health issues and to predict responders and non-responders for targeted medical nutrition therapy.

SNP Therapeutics Inc is a genetic testing company founded by Steven Zeisel, MD, PhD, Professor of nutrition and pediatrics at the University of North Carolina - Chapel Hill and Founding Director of the UNC Nutrition Research Institute.

The Genate™ Test - The first gene-guided prenatal precision nutrition test to help expectant mothers make the right decisions regarding One-Carbon & Fatty Acid nutrition, critical for proper cognitive development.
Reporting on Important Nutrient deficiency risk include Choline, Methyl folate, DHA, Betaine, B-12, Phosphatidylcholine, Oleic Acid
Easy Administration with “At Home” Saliva Test

Developed from academic research, the Genate Test measures 317 SNPs in 22 genes that regulate 5 metabolic pathways of nutritional synthesis and delivery.
Pathways include:
Choline Metabolism
Phosphatidylcholine Synthesis
Fatty Acid Metabolism and Transport (DHA/Omega 9)
Methyl folate Metabolism
Methylation

SNP Therapeutics

Org chart

Teams

Offices